Zehrung, D.; Innis, B.L.; Suwantika, A.A.; Ameri, M.; Biellik, R.; Birchall, J.C.; Cravioto, A.; Jarrahian, C.; Fairlie, L.; Goodson, J.L.;
et al. Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations. Vaccines 2024, 12, 1258.
https://doi.org/10.3390/vaccines12111258
AMA Style
Zehrung D, Innis BL, Suwantika AA, Ameri M, Biellik R, Birchall JC, Cravioto A, Jarrahian C, Fairlie L, Goodson JL,
et al. Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations. Vaccines. 2024; 12(11):1258.
https://doi.org/10.3390/vaccines12111258
Chicago/Turabian Style
Zehrung, Darin, Bruce L. Innis, Auliya A. Suwantika, Mahmoud Ameri, Robin Biellik, James C. Birchall, Alejandro Cravioto, Courtney Jarrahian, Lee Fairlie, James L. Goodson,
and et al. 2024. "Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations" Vaccines 12, no. 11: 1258.
https://doi.org/10.3390/vaccines12111258
APA Style
Zehrung, D., Innis, B. L., Suwantika, A. A., Ameri, M., Biellik, R., Birchall, J. C., Cravioto, A., Jarrahian, C., Fairlie, L., Goodson, J. L., Kochhar, S., Kretsinger, K., Morgan, C., Mvundura, M., Rathi, N., Clarke, E., Mistilis, J. J., Uwamwezi, M.-C., Giersing, B.,
& Hasso-Agopsowicz, M.
(2024). Measles–Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations. Vaccines, 12(11), 1258.
https://doi.org/10.3390/vaccines12111258
